Cannabis hopes bolster drugs firm
86048
A prescription cannabis medicine made by UK biotech firm GW Pharmaceuticals is set to be approved in Canada, sending its shares more than 8% higher.
769853
An active extract from the cannabis plant could be used to reduce the size of brain tumours and other cancers by restricting their ability to grow blood vessels to feed themselves, according to Spanish researchers.
697549
New drug prospects push shares to a new 52-week high.
738382
The drug maker is poised to speed past its rivals.
632263
Late-stage drugs are crucial for a company beset with patent losses.
532011
British and French pharmaceutical  companies are racing ahead of their U.S. counterparts to  develop new drugs containing marijuana to relieve pain and  treat a wide range of illnesses because marijuana is illegal in  the United States, scientific researchers said on Wednesday.
356950
Consolidation in Europe's drugs   sector gathered steam on Thursday as Germany's Merck unveiled a   $13.3-billion deal to buy Europe's top biotech firm Serono, and   Denmark's Nycomed won the drugs unit of Altana.
60071
The company's new smokeless product could help it capitalize on a growing trend.
430908
This little drug maker has the potential for big profit, in both the U.S. and Europe.
3935
Smoking large amounts of cannabis for therapeutic reasons may increase rather than reduce pain, a US study suggests.
521740
A study of cannabis-based drugs shows long-term benefit in easing multiple sclerosis symptoms, scientists say.
160226
The contract drug research company shares surged as the firm showed signs of new life.
759033
The chemical in cannabis that produces a high may help to combat the spread of cancer, research suggests. Scientists have discovered the active ingredient, delta-9-tetrahydrocannibol can block the spread of gamma herpes viruses.
583185
Consolidation in Europe's drugs  sector gathered steam on Thursday as Germany's Merck unveiled a  $13.3-billion deal to buy Europe's top biotech firm Serono, and  Denmark's Nycomed won the drugs unit of Altana.
762552
Its sales were up for the quarter, but a new drug might be the best indicator of its prospects.
161580
Britain&#39;s GW Pharmaceuticals Plc said on  Tuesday its pioneering cannabis-based drug Sativex had  qualified to be considered for approval by Canadian regulators  as a treatment for cancer pain.
423754
Consolidation in Europe's drugs   sector gathered steam on Thursday as Germany's Merck MRCG.DE   unveiled a $13.3-billion deal to buy Europe's top biotech firm   Serono SEO.VX, and Denmark's Nycomed won the drugs unit of   Altana ALTG.DE.